Survey Procedures and Interpretive Guidelines for Laboratories and Laboratory
Services (Clinical Laboratory Improvement Amendments (CLIA))
• Regional Office (RO)and State Agency(SA) surveyors, professional and accrediting organizations (AO);
• Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC);
• CMS Office of General Counsel (OGC); and
• General Accounting Office (GAO) on reporting complaints.
• Removal of Clinical Laboratory Standards Institute (CLSI) and CLSI standards and guidance documents.
It also includes:
• Patient Access regulatory changes and guidance on Patient Access to Test Reports;
• Proficiency testing regulatory changes and definitions;
• New D-tags for surveyors; and
• New name for the American Board of Medical Genetics (ABMG)